This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Tue Jun 18, 2013 8:12 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Mon Jul 31, 2006 7:51 pm 
Offline
Family Elder
User avatar

Joined: Sat Feb 18, 2006 4:00 pm
Posts: 516
Location: suburb of Chicago, IL USA
Seems encouraging but of course nothing concrete yet...

Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients.

Ni XS, Ouyang J, Zhu WH, Wang C, Chen B.

Department of Neurology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, China.

To observe the efficacy and toxicity of autologous hematopoietic stem cell transplantation (HSCT) in progressive multiple sclerosis (PMS). Twenty-one patients with PMS were treated with autologous HSCT. Stem cells were mobilized with cyclophosphamide (CY) and granulocyte colony-stimulating factor. After conditioning regimen of CY and total body irradiation or BEAM, stem cells were reinfused. CD34(+) cell selection of the graft was performed and anti-thymocyte globulin was given for T-cell depletion. The probabilities of confirmed progression-free survival and disease activity-free survival were used to assess the efficacy and the adverse experiences were recorded to detect the toxicities. The median follow-up time was 42 (6-65) months. The probabilities of confirmed progression-free survival and the disease activity-free survival were 75% and 33.3%, respectively. The principal adverse events included allergy, infection, elevation of liver enzymes, transient neurologic deterioration and depression. Two patients died of severe pneumonia and varicella-zoster virus hepatitis, at 4.5 and 15 months post-transplant, respectively. Autologous HSCT seems beneficial to PMS. However, more patients and longer follow up would be required to assess the risk/benefit ratio.


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Currently going through stem cell transplant

binder

2

1717

Sat Jun 17, 2006 2:12 am

bromley View the latest post

There are no new unread posts for this topic. Going for Stem Cell Transplant!!!

FollowMaggi

0

990

Thu Jun 10, 2010 2:39 pm

FollowMaggi View the latest post

There are no new unread posts for this topic. FDA approve stem cell transplant

bromley

0

1270

Fri Oct 21, 2005 8:05 am

bromley View the latest post

There are no new unread posts for this topic. Stem cell transplant for different disease

bromley

0

1330

Thu Jul 20, 2006 4:03 am

bromley View the latest post

There are no new unread posts for this topic. The Best Place for Stem Cell Transplant Is?

jam

3

1639

Thu Nov 12, 2009 5:20 pm

jam View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

Advertise on the premier multiple sclerosis forum